Reinhold Cohn & HealthIL
Startup Competition

8.12.21 | EXPO TLV

Connecting exceptional tech solutions with leading corporations and investors

Do not miss the opportunity to pitch in front of key executives from global corporations and investment funds in the Healthcare industry, to discuss real business opportunities and also win up to 100,000 ILS worth in prizes, including full patent application drafting.



The Reinhold Cohn Group and HealthIL are holding the Reinhold Cohn & HealthIL Startup Competition aiming at finding scalable technological solutions to varied challenges in the domain of Healthcare, by connecting global organizations & innovative startups.

The Reinhold Cohn Group (RCG) is the earliest and leading Intellectual Property consulting firm in Israel, representing Israel’s most promising startups, and leading multinational corporations for more than 85 years. 

HealthIL is the leading health innovation ecosystem in Israel; focused on a holistic, challenge-centric approach to integrating innovative solutions to healthcare systems. HealthIL is a joint venture of the Israel Innovation Institute, Israel's Ministry of Economy, Digital Israel at the Ministry of National Digitization, the Israel Innovation Authority and the Ministry of Health


Win a 100,000 NIS Worth of Prize Packages


2nd place

 IP services worth 20K NIS

By Reinhold Cohn Group

Digital marketing consulting and storytelling services worth 3K USD by Oktopus


1st place

Full drafting and filing of one patent application in a single territory - worth 30K NIS 
By Reinhold Cohn Group

Digital marketing consulting and storytelling services worth 5K USD by Oktopus


3rd place

 IP services worth 10K NIS

By Reinhold Cohn Group

Digital marketing consulting and storytelling services worth 2K USD by Oktopus

All finalists will have the opportunity to exhibit and pitch at the HealthIL week main event in front of hundreds of investors and industry leaders





In partnership with

Coming soon


Who Can Apply

The competition is open to early stage startups (seed to A round) with a working MVP, developing innovative technologies addressing one or more of the challenges detailed below. (see full terms and conditions)

Please note that before submission of new technological ideas within the framework of the context the participants should consider filing the appropriate application for the protection thereof. Publication of a new technology might jeopardize its novelty.

You are hereby invited to consult one of our professional patent attorneys in this regard.


BioMaterials & BioConvergence


Diagnostic Systems and Companions


Drug Delivery and Development




October 19

Application opens

November 15

Application closes

November 21

Finalists announced

December 8

Grand Final Pitch event


Meet the Judges


Coming soon

Dr. Emily Rozenshine
Head of Strategy and Business Development Cloud & AI BG, Tel Aviv Research Center Huawei Technologies Co., Ltd